#South Korea #Seoul #Sky Labs #CART BP pro #Hypertension Guidelines

The Revolutionary Ring-Type Blood Pressure Monitor

In a groundbreaking advancement for hypertension management, Sky Labs has announced that its innovative ring-type cuffless blood pressure monitor, 'CART BP pro', has officially been integrated into the 2026 Korean Society of Hypertension Guidelines for the management of hypertension. This historic inclusion marks a pivotal moment in healthcare, as the 'CART BP pro' is the first cuffless monitor in the world to receive this recognition.

The announcement was made on May 26, 2026, and the official guidelines were showcased earlier at the Korean Society of Cardiology's spring conference. The inclusion of the CART BP pro as a recommended clinical tool for out-of-office blood pressure measurement reflects a significant shift in the way hypertension is managed within the healthcare system. Notably, this recognition positions South Korea as a leader in adopting cuffless technology for blood pressure monitoring, moving away from traditional methods that often rely on cumbersome cuff devices.

A Breakthrough for Hypertension Patients

The Korean Society of Hypertension emphasizes that the 'CART BP pro' can now be utilized for more effective monitoring of patients, particularly those with conditions requiring stringent blood pressure control, such as diabetes and chronic kidney disease. The guidelines have set a target blood pressure goal of below 130/80 mmHg, urging even greater precision in managing this critical health issue.

The CART BP pro's finger-worn design eliminates the need for standard cuffs, providing patients with the freedom to monitor their blood pressure seamlessly throughout their daily lives or while they sleep. This unique ability allows for precise tracking of conditions like nocturnal hypertension, which has been challenging to monitor effectively with traditional devices.

A study referenced in the guidelines revealed that around 18-23% of the general population experiences nocturnal hypertension, which is often undetectable in routine office measurements. Additionally, patients categorized as having masked hypertension—those who appear normotensive during regular checks but have high blood pressure at night—face heightened risks of complications.

Validated Accuracy and Real-World Impact

Sky Labs conducted thorough clinical trials demonstrating that CART BP pro meets the international accuracy standards, showing consistent performance compared to traditional 24-hour ambulatory blood pressure monitoring. Research indicated a mean error margin of under 5 mmHg with a standard deviation of less than 8 mmHg across various conditions, reinforcing its clinical applicability.

Since its reimbursement approval by South Korea's National Health Insurance system in June 2024, the 'CART BP pro' has been prescribed over 250,000 times in hospitals and clinics. This uptake underlines the product’s acceptance in clinical settings and signifies a shift in how hypertension can be effectively managed.

Looking Ahead: Expanding Horizons

Jack ByungHwan Lee, CEO of Sky Labs, commented on this milestone, stating, “The integration of CART BP pro into the KSH guidelines illustrates Korea's leadership in advancing cuffless blood pressure technology globally. With robust clinical evidence backing this innovative device, we are poised to accelerate our efforts for international regulatory approvals and set new standards in hypertension management.”

The ripple effect of this innovation could reshape portable monitoring practices worldwide, potentially enhancing patient outcomes and creating a more proactive approach to blood pressure management. As healthcare continues to evolve, the 'CART BP pro' symbolizes the future of medical monitoring—one that prioritizes convenience, accuracy, and comprehensive care.

Conclusion

With its cutting-edge technology and impactful practical applications, the 'CART BP pro' stands at the forefront of a revolution in how hypertension is treated, promising to deliver better healthcare experiences and outcomes for patients everywhere. As the demand for effective monitoring grows, solutions like the CART BP pro may very well become the new normal in blood pressure management.